The proximity of organs at risk makes the treatment of head and neck squamous cell carcinoma (HNSCC) challenging by standard radiotherapy. The higher precision in tumor targeting of proton (P) therapy could promote it as the treatment of choice for HNSCC. Besides the physical advantage in dose deposition, few is known about the biological...
-
July 2017 (v1)Journal articleUploaded on: December 4, 2022
-
2019 (v1)Journal article
Lysosomotropic agents such as sunitinib, lapatinib, and chloroquine belong to a drug family that is being used more frequently to treat advanced cancers. Sunitinib is standard care for metastatic renal cell carcinomas (mRCC) and lapatinib is used for trastuzumab/pertuzumab-refractory cancers. However, patients ineluctably relapse with a delay...
Uploaded on: December 4, 2022 -
December 8, 2020 (v1)Publication
No description
Uploaded on: February 22, 2023 -
December 8, 2020 (v1)Publication
No description
Uploaded on: December 4, 2022 -
January 21, 2019 (v1)Journal article
International audience
Uploaded on: December 4, 2022